Type-2 diabetes is associated with a chronic low-grade systemic inflammation accompanied by an increased production of adipokines/cytokines by obese adipose tissue. The search for new antidiabetic drugs with different mechanisms of action, such as insulin sensitizers, insulin secretagogues and aglucosidase inhibitors, has directed the focus on the potential use of flavonoids in the management of type-2 diabetes. Thirty six diabetic male C57BL/6J db/db mice were fed a standard diet and randomly assigned into four experimental groups: non-treated control, (n ¼ 8); acarbose (5 mg per kg bw, n ¼ 8);
Introduction
Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by chronic hyperglycemia as a result of impairments in insulin secretion and insulin action in target tissues.
1 Insulin resistance (IR) is produced as soon as the pancreatic b-cells cannot compensate a reduced insulin function, leading to elevated circulating glucose levels.
2 Insulin inhibits gluconeogenesis in the liver and reduces lipolysis in adipose tissue. 3 Likewise, adipose tissue in diabetes and obesity is characterized by hypertrophy, relative hypoxia, low-grade chronic inamma-tion and endocrine dysfunctions. 4 In this context, the proinammatory cytokines, many of them secreted by the hypertrophied adipocytes, are controlled through transcription nuclear factor-kappaB (NF-kB), whereby the inammatory response can be down-regulated. 5 In addition, this transcription factor represents a link between inammation and IR, as it is activated by factors known to promote IR and T2DM. 6 One important downstream target of NF-kB is cyclooxygenase 2 (COX2), which catalyzes the production of prostaglandins, the key molecules in inammation processes of the body. 7 Moreover, NF-kB is involved in the expression of many cytokines, including TNFa. 5 On the other hand, epigenetic changes are heritable yet reversible modications that occur without alterations in the primary DNA sequence. These modications may provide a link between the environment (i.e. nutrition) and T2DM. 8 Recently, epigenetic modications have also been implicated in disease-associated changes inuencing gene expression. 9 Targeting the reduction of chronic inammation is a benecial strategy to combat several metabolic diseases, including T2DM. 10 Thus, numerous studies have underlined the interest in nding nutritional factors that may help to prevent or treat these diseases. 10, 11 In this sense, avonoids can act through a variety of mechanisms to prevent and attenuate inammatory responses. 12 These bioactive compounds can also improve glucose metabolism by stimulating the peripheral glucose uptake in different tissues. 11 In relation to this, grapefruit extract is rich in avanones (i.e., naringenin-7-O-rutinoside) and avonols (i.e., kaempferol rutinoside). 13 Previous studies have reported that citrus avonoids have many pharmacological activities, including anti-inammatory properties.
14 Thus, an improvement in hyperglycemia by the hepatic enzymes involved in glucose metabolism was reported in the groups of mice whose diet was supplemented with naringin. 15 Furthermore, a recent study reported that orange juice appears to mediate the inammatory response, both at gene expression and plasma levels. 16 Helichrysum (Helichrysum italicum) is a owering plant that grows around the Mediterranean area and contains naringenin-7-O-glucoside, kaempferol-3-O-glucoside and other avonoids.
13
Likewise, plants of the Helichrysum genus have been found to have several biological activities, such as anti-inammatory properties, which have been attributed to different avonoids.
17
Thus, benecial roles of kaempferol have been reported in inammation, hyperglycemia and diabetes using different in vitro and in vivo models. 18 In addition, some investigations concluded that the anti-inammatory activity of Helichrysum italicum may be explained by enzyme inhibition, free-radical scavenging activity and corticoid-like effects. 19 In this sense, our group previously demonstrated that helichrysum and grapefruit extracts ameliorated hyperglycemia by inhibiting a-glucosidase (a similar mechanism to acarbose) and a-amylase enzyme activities and by decreasing the SGLT1-mediated glucose uptake in the gut.
13
Since inammation in adipose tissue plays a central role in obesity-related IR and T2DM, our research was conducted using a recognized model of obesity and diabetes, db/db mice, displaying characteristics such as overweight, hyperglycemia and hyperinsulinemia due to leptin receptor mutations. 20 Therefore, the aim of this study was to investigate the antihyperglycemic and anti-inammatory effects of helichrysum and grapefruit extracts, studying the possible involvement of epigenetic mechanisms in db/db mice. The effects of both extracts were compared with those of acarbose, an oral anti-diabetic agent whose main mechanism of action is the inhibition of a-glucosidase.
Materials and methods

Chemicals
Mice were fed a standard pelleted chow diet from Harlan Ibérica (Teklad Global, Barcelona, Spain; ref. 2014). Helichrysum (Helichrysum italicum) and grapefruit (Citrus x paradisi) extracts, as well as acarbose®, were provided by "Biosearch S.A." (Granada, Spain). Plant samples (1-5 g) were pulverized, mixed with washed sea sand and introduced into the extraction cells, where 30 mL of each solvent at 50 C was added: methanol/water (3 : 1)
and methanol-water (1 : 1) for helichrysum and grapefruit, respectively. The quantication of the phenolic compounds was performed by UPLC-MS/MS. 13 Helichrysum extract contained phenolic acids and avonoids as avanones and avonols subclasses, as previously described. 13 The avanones found in higher proportions were naringenin-7-O-glucoside (3.9 mg g À1 extract) and naringenin diglycoside (1.2 mg g À1 extract).
Kaempferol-3-O-glucoside (13.4 mg g À1 extract) is the avonol that was found in a greater proportion. Likewise, the grapefruit extract mainly contained naringenin-7-O-rutinoside (5.2 mg g À1 extract) and naringenin (1 mg g À1 extract) as avanones, and kaempferol-rutinoside (54.2 mg kg À1 extract) as a avonol.
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Glucose was purchased from Sigma-Aldrich (St. Louis, MO, USA) and starch (162.14 g mol
À1
) from Panreac (Barcelona, Spain).
Experimental animals
Thirty six overweight and diabetic male C57BL/6J db/db mice (Charles River, Barcelona, Spain) were randomly assigned into four experimental groups: non-treated control group, n ¼ 8; acarbose group (5 mg per kg bw), n ¼ 8; helichrysum group (1 g per kg bw), n ¼ 10, and grapefruit group (0.5 g per kg bw), n ¼ 10. The doses used were calculated by comparing with the acarbose effect and based on the IC 50 of the extracts, as described elsewhere. measurements were performed by using an Oxylet equipment (Panlab, Barcelona, Spain), as previously reported. 21 This procedure was carried out in groups of four mice daily, introducing each mouse in a box with water and food during 24 hours. At weeks 3 and 6, the oral starch tolerance test (OSTT) and intraperitoneal glucose tolerance test (IPGTT) were carried out, respectively. Aer 6 weeks of experimental treatment, mice were killed by decapitation and trunk blood was collected to obtain serum for the biochemical measurements. Liver, pancreas, spleen and different adipose depots, such as subcutaneous, retroperitoneal, epididymal and mesenteric, were carefully dissected and weighed. Tissue samples and serum were immediately frozen in liquid nitrogen and stored at À80 C for further analyses. All the procedures were performed according to the guidelines of the Animal Research Ethics Committee of the University of Navarra (04/2011).
Oral starch tolerance test (OSTT) and intraperitoneal glucose tolerance test (IPGTT)
per kg bw) with starch (2 g per kg bw in 30% w/v solution) and acarbose (5 mg per kg bw), helichrysum (1 g per kg bw) and grapefruit (0.5 g per kg bw), respectively. were determined by the trapezoidal rule.
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Biochemical measurements
Fasting glucose levels were measured with the HK-CP kit (ABX diagnostic, Montpellier, France), creatinine was determined with the Creatinine-CP kit (ABX Pentra), and triglycerides with the RANDOX triglycerides kit (Randox Laboratories, Crumlin, UK), adapted for the PENTRA C200 equipment (HORIBA Medical, Montpellier, France). The levels of glycated hemoglobin (HbA1C) were determined at the end of the feeding period and measured with the mouse GHbA1C ELISA kit (Cat. no. CSB-E08141m, Cusabio Biotech Co., Ltd., China). The pancreatic insulin content was determined by acidethanol extraction. Briey, the pancreas was placed in 5 mL acid-ethanol (1.5% HCl in 70% EtOH) overnight at À20 C, homogenized and incubated overnight at À20 C. Samples were centrifuged at 2000 rpm for 15 minutes at 4 C. The supernatant was transferred to clean tubes and neutralized with 100 mL 1 M Tris, pH 7.5. The pancreatic insulin content was analyzed by the enzyme-linked-immunosorbent assay (ELISA) following the protocol described by the manufacturer (Mercodia AB, Uppsala, Sweden). The absorbance was calculated with an appropriate dilution factor. Pancreatic insulin values were corrected for the protein concentration, as determined by the Bradford assay with bovine serum albumin as a standard (Bio-Rad Protein Assay, Bio-Rad Laboratories, Hercules, CA, USA). Finally, the insulin content (ng mL À1 ) was normalized by the protein content (mg mL
À1
).
RNA extraction, reverse transcription and quantitative realtime polymerase chain reaction (RT-PCR) analysis
Total RNA was extracted from pancreas, liver and epididymal adipose tissue using TRIzol® reagent (Invitrogen, CA, USA) according to the manufacturer's instructions. RNA concentration and quality were measured with a Nanodrop Spectrophotometer 1000 (Thermo Scientic, Delaware, USA). Then, RNA (2 mg) was reverse-transcribed to cDNA using MMLV (Moloney murine leukemia virus) reverse transcriptase (Invitrogen). RT-PCR assays were performed following the manufacturer's recommendations using an ABI PRISM 7000 HT Sequence Detection System and predesigned TaqMan® Assays-onDemand by Applied Biosystems (Texas, USA). Glucokinase (GCK), Mm00439129_m1; glucose 6-phosphatase (G6Pase), Mm00839363_m1; phosphoenolpyruvate carboxykinase (PEPCK), Mm01247058_m1; monocyte chemotactic protein 1 (MCP1), Mm00656886_g1; nuclear factor-kappaB (NF-kB), Mm00476361_m1; cyclooxygenase 2 (COX2), Mm00478374_m1; tumor necrosis factor a (TNFa), Mm00443260_g1; betatrophin, Mm01175863_g1; Insulin (Ins1), Mm019550294_s1; Insulin receptor (InsR), Mm01211875_m1; glucose transporter 4 (GLUT4), Mm00436615_m1 and Taqman Universal Master Mix were also provided by Applied Biosystems. The mRNA levels were normalized using glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Mm 99999915_g1 and beta actin (ActB), Mm 00607939_s1, as housekeeping genes. All samples were analyzed in triplicate. The relative expression level of each gene was calculated by the 2 ÀDDCt method.
DNA extraction and bisulte conversion
Genomic DNA was isolated from epididymal adipose tissue using the DNA purication protocol for tissues of the QIAamp DNA Mini Kit (Qiagen, Germantown, MD, USA). DNA concentration and quality were measured by using a Nanodrop Spectrophotometer 1000 (Thermo Scientic, DE, SA). The stock solutions of DNA samples were stored at À80 C until use. For epigenetic analysis, all DNA samples were bisulte-treated using the EpiTect Bisulte Kit (Qiagen, Hilden, Germany), resulting in the deamination of unmethylated cytosine to uracil. The concentration of DNA was measured on a Pico100 (Picodrop Limited, Hinxton, UK). All procedures were carried out according to the manufacturer's instructions.
PCR and methylation analysis by DNA pyrosequencing
Quantitative methylation analyses were performed by pyrosequencing of bisulte-converted DNA using PyroMark Q24 (Qiagen). PCR was carried out in 25 mL reaction mixtures containing 12.5 mL PyroMark 2Â PCR master mix, 0. agarose gel electrophoresis. A total of 22 mL of the PCR product was used for subsequent pyrosequencing using a PyroMark Q24 System (Qiagen). All procedures for quantication of CpG methylation levels were performed based on a protocol described elsewhere. 23 For quality control, each experiment included non-CpG cytosines as internal controls to verify efficient bisulte DNA conversion.
Statistical analysis
All the results are expressed as mean AE standard deviation (SD) of the mean. Statistical signicance of differences among the groups was evaluated using the One-Way ANOVA test followed by the Dunnett's post-hoc test. The two-tailed Pearson test was used to assess selected correlations among variables. A level of probability of p < 0.05 was set as statistically signicant. All analyses were performed using SPSS 15.0 packages for Windows (Chicago, IL).
Results
Food intake, body weight gain and body fat mass
At the end of the supplementation period, the grapefruit group gained more body weight (p < 0.05) than the non-treated group (Table 1) . Although not statistically signicant, the percentage of total adipose tissue (WAT) was slightly higher in the treated groups (Table 1) . Furthermore, signicant differences were found in spleen weight between the acarbose (p < 0.05) and helichrysum (p < 0.01) groups when compared with the nontreated group, whereas liver weights were similar in all groups (Table 1) .
Regarding food efficiency, the average daily food intake throughout the experimental period remained unaltered in the acarbose group and aer helichrysum and grapefruit extract administration (Table 1) .
Respiratory quotient and energy expenditure
The respiratory quotient (RQ) assessment, which is used to evaluate the relative oxidation of substrates, evidenced that the grapefruit group (p < 0.05) improved carbohydrate oxidation when compared with the non-treated group (Table 1) . Otherwise, there were no differences among groups with respect to energy expenditure (EE), suggesting that the possible effect of helichrysum and grapefruit extracts on glucose metabolism did not signicantly affect thermogenesis (Table 1) .
Blood glucose and serum parameters
Glycemia levels at baseline and at the end of the supplementation period are shown in Table 1 . All mice were diabetic when the experiment began (x ¼ 10 AE 3 mmol L À1 ). Although no signicant differences were found in the acarbose group, both supplemented groups showed signicantly lower levels of glycemia (p < 0.05) at the end of the 6-week treatment when compared with the non-treated group (Table 1 ). The grapefruit group showed a decreased glucose AUC in the OSTT (p < 0.05) (Fig. 1A) . Likewise, both supplemented groups showed lower AUC than the non-treated group in the IPGTT (p < 0.05) (Fig. 1B) .
No statistically signicant differences between groups were found in fasting triglyceride levels. Conversely, creatinine serum levels were slightly lower in the acarbose and grapefruit groups, but did not reach statistical signicance in comparison with the non-treated group (Table 1) .
The long-term glucose control was also evaluated by measuring HbA1C (Table 1) , but no relevant differences were found among the experimental groups.
Determinations in the pancreas
Pancreatic insulin content was analyzed to determine whether the use of both extracts might have benecial effects on glucose metabolism via the insulin secretory capacity of the pancreas. There were no differences in the pancreatic insulin content among the experimental groups (Table 1) . However, the mRNA expression of Ins1 was decreased in the pancreas from the acarbose group when compared with the non-treated group (data not shown). No statistical differences were found between groups in the mRNA expression of GCK in the pancreas (data not shown).
Glucose metabolism
In order to investigate the mechanisms through which avo-noid-rich extracts ameliorate hyperglycemia in db/db mice, the mRNA expression of different genes that regulate glucose homeostasis in the liver was examined (Table 2) . GCK expression levels were statistically higher in the acarbose group (p < 0.001) and both supplemented groups (p < 0.05) when compared with the non-treated group. No statistically signi-cant differences were found in G6Pase, PEPCK and betatrophin mRNA levels in the liver (Table 2) . Interestingly, mRNA expression levels of GCK in the liver showed a negative a Results are expressed as mean AE SD. Statistical analysis was performed using ANOVA, and the Dunnett's test was used to analyze differences in the mean of each group compared with the non-treated group. Non-treated and acarbose groups (n ¼ 6); helichrysum and grapefruit groups (n ¼ 8). *p < 0.05; **p < 0.01.
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View Article Online correlation (r ¼ À0.692, p < 0.001) with nal blood glucose levels (mmol L À1 ) (Fig. 2) .
Moreover, mRNA expression levels of betatrophin, InsR and GLUT4 were measured in epididymal adipose tissue, although no differences were found among the experimental groups (Table 3) .
Inammatory markers
The expression of several pro-inammatory markers was analyzed in the liver and epididymal adipose tissue. Thus, the hepatic mRNA levels of TNFa, MCP1, COX2 and NF-kB decreased in the acarbose group and aer supplementation with both the helichrysum and grapefruit extract ( Table 2) . Statistically signicant differences in the mRNA expression of TNFa, MCP1 and COX2 were also found in epididymal adipose tissue, but only in the groups supplemented with the natural extracts (Table 3) .
DNA methylation analysis
The methylation pattern of TNFa was analysed in epididymal adipose tissue (Fig. 3) . Interestingly, a hypermethylation (D of methylation: 2.5%) was detected at CpG3 (CpG site + 5 bp) aer supplementation with the grapefruit extract (p < 0.01) (Fig. 3B) . Moreover, TNFa CpG3 methylation levels (%) showed a positive correlation with body weight gain (g) (r ¼ 0.562, p < 0.05) and WAT (%) (r ¼ 0.706, p < 0.01) (Fig. 3C) , suggesting a link between DNA methylation, inammation and adipose tissue mass.
Discussion
Persistent efforts to identify potential compounds that can be useful in the control and treatment of T2DM have been devoted. In this sense, avonoids are attractive candidates because of their widespread presence in nature and their potential pharmacological effects.
11 Flavonoids are bioactive constituents abundantly present in the grapefruit and helichrysum extracts. Different in vitro and in vivo studies have shown benecial roles of avonoids in inammation, 6,10 hyperlipidemia 24,25 and diabetes.
11 With regard to the antidiabetic effects of the 6 week supplementation with grapefruit and helichrysum extracts, lower fasting blood glucose levels were found when compared with the non-treated db/db mice. At the end of the experimental period, we noted that the mice were already in a state of diabetes with symptoms that caused severe metabolic disturbances. However, the grapefruit extract administration apparently delayed cachexia associated with diabetes and showed slightly higher levels of RQ, suggesting a better management of the carbohydrate metabolism. The improvement in metabolic glucose utilization as an energy source was signicantly correlated with the results obtained from the OSTT. Concerning the molecular mechanisms implicated, previous studies have shown that avonoids can improve glucose metabolism by stimulating peripheral glucose uptake in adipose tissue. 26, 27 GLUT4, an insulin sensitive glucose transporter, plays an important role in glucose transport in peripheral tissues. 28 Thus, hesperidin and naringin enhanced GLUT4 expression in WAT in type-2 diabetic mice. 29 Likewise, naringenin improved insulin-stimulated glucose uptake in 3T3-L1 cells.
30 Kaempferol and kaempferol 3-neohesperidoside (the avonoid glycoside) showed insulinomimetic effects and stimulation of glucose uptake in differentiated 3T3-L1 adipocytes. 31, 32 Conversely, in our study no signicant differences among the experimental groups were found in the expression of GLUT4 and InsR in adipose tissue. However, although not statistically signicant, a slight increase in the betatrophin gene expression of supplemented groups was found. The expression of betatrophin in adipose tissue may be an indicator of the action of pancreatic b-cells, Furthermore, it has been reported that avonoids may directly act on pancreatic b-cells. 34 In an in vitro study, naringenin downregulated the expression of GCK and Ins1, suggesting an enhancement of glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells. 35 In the present study, no signicant differences were found in the expression of GCK and Ins1 in the pancreas, which might be due to different factors like the dosage used, and the time or the period of supplementation.
In the liver, glucose is phosphorylated by glucokinase (GCK) and, depending on the cell's requirements, can be stored via glycogenesis activation (PEPCK) or oxidized to generate ATP (glycolysis). In this sense, previous studies have shown that dietary supplementation with hesperidin and naringin improved hyperglycemia by altering the expression of genes involved in glycolysis and gluconeogenesis in the liver.
14,15 Jung et al. 29 have shown an increased liver expression of GCK aer administering hesperidin and naringin in db/db mice, whereas naringin reduced the expression of PEPCK and G6Pase. Moreover, the inhibition of PEPCK decreased the hepatic glycogen content and nally improved the glucose metabolism. Park et al.
14 have found a signicantly lower expression of PEPCK in the liver of db/db mice supplemented with citrus extract. However, they did not nd signicant differences in the G6Pase expression. In our study, no signicant differences were observed in the expression of PEPCK and G6Pase in the liver. Meanwhile, the liver GCK expression was signicantly higher in the mice supplemented with grapefruit and helichrysum extracts, suggesting that the antidiabetic effects may occur in the liver by modulating the enzymes involved in glycolysis and gluconeogenesis. Thus, there is a negative correlation between blood glucose levels and liver GCK expression (p < 0.001), Table 3 Effects of flavonoid-containing extracts from helichrysum and grapefruit on mRNA expression levels in epididymal adipose tissue. Genes related to glucose metabolism and inflammation suggesting that the decrease of glucose levels may be related to the increase of liver glucose sensitivity.
Several studies have reported that the down-regulation of inammatory cytokine genes, including TNFa and MCP1, protects against the development of insulin resistance and hyperglycemia in obese mice. [36] [37] [38] Flavonoids might also act by interfering with the secretion of pro-inammatory cytokines, thus improving the state of T2DM and obesity. 10 In this sense, mice supplemented with kaempferol showed an inhibition of proinammatory gene expression by modulating the NF-kB signaling cascade. 39 Likewise, Park et al. 40 have shown that kaempferol also inhibited COX2, iNOS and MCP1 gene expression in the kidney of aged Sprague-Dawley rats. Our data indicates that the supplementation with grapefruit and helichrysum extracts seems to have a favorable effect on the inammatory status of db/db mice. In cultured cells, lipopolysaccharide (LPS)-stimulated macrophages treated with naringenin presented lower expression of TNFa and IL-6. 41 Several studies in animals analyzing the effects of citrus avonoids have also shown a preventive effect on obesity-and diabetes-associated inammation. 11, 24, 25 Thus, mice treated with naringin showed lower serum TNFa levels, 42 whereas naringenin and naringin suppressed the activation of NF-kB. 43 Although the inamma-tory pathways regulated by these avonoids have not been fully elucidated, a recent study suggested that local upregulation of TNFa in the intestine was more sensitive than circulating cytokine levels. 44 Recent studies have found that TNFa is a key player in adipose tissue chronic inammation, inducing the activation/inhibition of signaling cascades that perpetuate the inammatory status and cause insulin resistance and hyperlipidemia by activating NF-kB. 45 TNFa is usually overexpressed in adipose tissue in different animal models of obesity and insulin resistance.
46
Concerning epigenetic modications, DNA methylation may inuence the pathogenesis of T2DM and inammation;
1,47 and dietary factors are a major aspect of the environment that may inuence DNA methylation. 48 One of the epigenetic modica-tions of the TNFa gene is DNA methylation. 49 In this sense, we measured the methylation pattern of the promoter and rst exon of TNFa. The results suggest that the DNA methylation levels of TNFa were higher in the db/db mice supplemented with the grapefruit extract. Interestingly, we have found correlations between DNA methylation in the CpG3, body weight gain and the percentage of WAT. Previous studies of our group have evidenced the role of dietary factors on the modulation of TNFa DNA methylation, 50 and have reported that the promoter methylation levels of TNFa could be used as an epigenetic biomarker for identifying the response to a low-calorie diet in obese women.
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To date, no study with citrus avonoids and kaempferol has analyzed their effects on DNA methylation. However, other bioavonoids, such as quercetin, setin, myricetin and tea catechins, have been reported to exert an effect on this epigenetic mechanism.
9,51
These results suggest that epigenetic changes in TNFa could subsequently contribute to ameliorate inammation and nally improve insulin resistance-induced hyperglycemia. The supplementation with helichrysum and grapefruit extracts shows benecial effects against diabetes and obesity associated inammation in db/db mice. These changes may be due, at least in part, to small epigenetic modications that can be induced by the avonoids and other compounds found in the natural extracts. Regarding the implication of inammation in DNA methylation patterns, 52 avonoids could be an interesting therapeutic tool in the management of this situation. Thus, dening the role of epigenetic regulation of TNFa may lead to new therapeutic strategies for these metabolic diseases through modulation of the inammatory status. 53 However, more detailed studies at the molecular and cellular levels are needed to determine how both extracts exert their antidiabetic activity as well as the individual compounds with an increased effect.
In summary, helichrysum and grapefruit extracts modulate hyperglycemia and TNFa-mediated inammation in a diabetic model. Advances in this area may open the door to recognize the epigenetic regulatory role of different bioactive compounds involved in the metabolic control and the conditions that facilitate DNA methylation. 
